CDSCO to regulate Adhesives for fixing wigs, scalp cleansing products, artificial nails system, invites comments Medical Dialogues Bureau7 Nov 2019 5:01 PM ISTWith regard to artificial nails, it has been decided by CDSCO to incorporate a new category named ‘Artificial Nail Systems" in column 3 of the...
New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble Medical Dialogues Bureau7 Nov 2019 4:20 PM ISTCadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
Aurobindo Pharma gets 8 USFDA observations for 2 facilities in Hyderabad Medical Dialogues Bureau7 Nov 2019 9:45 AM ISTThe USFDA inspected active pharmaceutical ingredients (API) manufacturing facility (Unit V) at Pashamylaram and API manufacturing facility (Unit VIII)...
Novartis arm wins USFDA nod for biosimilar Ziextenzo in oncology care Medical Dialogues Bureau7 Nov 2019 9:30 AM ISTNew Delhi: Novartis division, Sandoz recently announced that the US Food and Drug Administration (USFDA) approved its biosimilar ZiextenzoTM...
Lupin posts Rs 123 crore net loss in Q2 Medical Dialogues Bureau7 Nov 2019 9:15 AM ISTLupin said it has agreed to pay Rs 450.06 crore as settlement in connection with the lawsuit in the US and, accordingly, a provision of Rs 379.18...
OxyContin maker Purdue Pharma gets interim shield from litigation Medical Dialogues Bureau7 Nov 2019 9:00 AM ISTU.S. Bankruptcy Judge Robert Drain said on Wednesday he would approve an order extending a stay on more than 2,600 lawsuits that accuse Purdue Pharma...
All formulations of Proton Pump Inhibitors have to carry warning for associated Acute Kidney Injury- CDSCO Direction Medical Dialogues Bureau6 Nov 2019 12:30 PM ISTNew Delhi: All formulations of Proton Pump Inhibitors marketed in the country including Pantoprazole, Omeprazole, lansoprazole, Esomeprazole,...
Alleged carcinogenic impurity in Ranitidine: Dr Reddy's Laboratories makes Rs 40-crore provisioning in PnL for market impact Medical Dialogues Bureau5 Nov 2019 12:52 PM ISTHyderabad: Dr Reddy's Laboratories, which initiated a voluntary recall of its Ranitidine from the US market following the ongoing investigation by the...
Unichem Labs net loss narrows to Rs 22 crore in September quarter Farhat Nasim5 Nov 2019 9:15 AM ISTUnichem Labs had posted a net loss of Rs 41.03 crore for the corresponding period of the previous fiscal, the company said in a filing to the BSE.New...
DoP invites nominations for 5th India Pharma and Medical Device Awards Medical Dialogues Bureau4 Nov 2019 5:23 PM ISTNew Delhi: The Government of India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals (DoP) has decided to confer 5th India...
Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA Medical Dialogues Bureau4 Nov 2019 4:31 PM ISTNew Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
GSK Benlysta gets European nod for treatment of children with lupus Medical Dialogues Bureau4 Nov 2019 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
